• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Rare case of drug-induced bradycardia associated with the just low dose use of methylprednisolone in a child with COVID-19

tetano

Editor, Senior Moderator
J Med Virol


. 2021 Dec 15.
doi: 10.1002/jmv.27525. Online ahead of print.
Rare case of drug-induced bradycardia associated with the just low dose use of methylprednisolone in a child with COVID-19


Ping Jiang[SUP] 1 [/SUP], Shuang-Hua Wu[SUP] 2 [/SUP], Ting Zhu[SUP] 3 [/SUP], Yuan Guo[SUP] 1 [/SUP], Yi He[SUP] 1 [/SUP]



Affiliations

Abstract

Methylprednisolone (MP) is usually used to reduce the inflammation reaction and tissue damage, which may have a benefit assistant treatment effect on coronavirus disease 2019 (COVID-19). However, We present the case of a child who manifest significant bradycardia with the use of just low dose MP on the premise of the long-term use of arbidol. Arbidol can affect the activity of CYP3A4 which is also a key metabolic enzyme of MP by competitive inhibition, which is easy to aggravate the side effects of the MP. Therefore, more attention should be paid with bradycardia occurrence in the patient with COVID-19 when MP is considered in COVID-19. This article is protected by copyright. All rights reserved.

Keywords: Coronavirus; Infection; Inflammation.
 
Back
Top Bottom